Unit Dose Manufacturing Market Projected to Gain Significant Value through 2032
According to Future Market Insights' newly released Unit Dose Manufacturing market analysis report, global sales of Unit Dose Manufacturing in 2021 will be US$ 18.3 Billion. The estimated market growth of 22.4% between 2022 and 2032 is expected to be much higher than the previous trend. During the projected period 2022 to 2032, Outsourcing is expected to be the largest revenue generating Type, while Solid Unit Dose is expected to be the highest revenue generating Filament, with a CAGR of 19.8% and 22.8%, respectively. The benefits associated with unit dose manufacturing including complete drug identification and the preservation of dosage form’s integrity until the time of administration is projected to enable the market loom further in double digit growth during the period of projection. If the drug has not been used and the container is still intact, it can be retrieved without jeopardizing the drug’s formulations. In addition, the FDA regulates unit dose-packed oral solid pharm